Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5383367 | 0.89 | F10 (0.36) | F10NPY2R | |
| SCHEMBL5371113 | 0.87 | F10 (0.47) | F10 | |
| SCHEMBL5380004 | 0.87 | F10 (0.47) | F10 | |
| SCHEMBL5380049 | 0.86 | F10 (0.39) | F10 | |
| SCHEMBL5386312 | 0.85 | F10 (0.39) | F10 | |
| SCHEMBL5380531 | 0.84 | F10 (0.38) | F10 | |
| SCHEMBL5379823 | 0.84 | F10 (0.38) | F10 | |
| SCHEMBL4508161 | 0.80 | F10 (0.35) | F10 | |
| SCHEMBL5936099 | 0.80 | F10 (0.47) | F10 | |
| SCHEMBL4851277 | 0.79 | F10 (0.47) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7235544-B2 | for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease | GLAXO GROUP LIMITED (GB) | 2007-06-26 | — | — | US | disclosed |